On Wednesday, 21 July 2010, the Global Campaign for Microbicides hosted a tele-briefing for advocates to discuss the findings of the CAPRISA 004 trial. We were joined by over 180 advocates and others from the field to learn more about and discuss these pivotal trial results. 

A heartfelt thanks goes to Professor Salim Abdool Karim for presenting on the results of the CAPRISA 004 trial in this forum for advocates. 

We would like to thank all the speakers who offered their expertise during the tele-briefing.

Speakers included: 

• Prof Salim Abdool Karim, Director of CAPRISA and Co-Principal Investigator of CAPRISA 004, South Africa
• Dr Gina Brown, Coordinator, Microbicides and Women and Girls Research, Office of AIDS Research, National Institutes of Health, USA
• Dr Samu Dube, Director of Africa Programmes, Global Campaign for Microbicides, South Africa
• Dr Henry Gabelnick, Executive Director, CONRAD, USA
• Dr Emmanuel Njeuhmeli, Senior Biomedical Prevention Advisor, USAID, USA
• Dr Jim Rooney, Vice President Medical Affairs, Gilead Sciences, Inc., USA
• Emily Bass, Program Director, AVAC, USA
• Yasmin Halima, Director, Global Campaign for Microbicides, USA, chair and moderator of an interactive discussion with participants

The call aimed to: 

     1.  Share results from the CAPRISA 004 microbicide trial;

     2.  Provide opportunities to ask investigators, researchers,

          product developers, and advocates questions about the study

          design, findings, and implications of the results;

     3.  Discuss next steps for microbicide and other biomedical 

          prevention research including oral pre-exposure prophylaxis

          (PrEP).